This inventor holds 1 USPTO granted patent. Top assignee: Immunomet Therapeutics Inc.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Kook Hwan Oh: Innovator in Pharmaceutical Composition
Introduction
Kook Hwan Oh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of fibrosis treatment. His innovative work has led to the development of a unique pharmaceutical composition that holds promise for medical applications.
Latest Patents
Kook Hwan Oh holds a patent for a pharmaceutical composition comprising N1-cyclic amine-N5-substituted biguanide derivatives. This invention is aimed at preventing or treating fibrosis. The novel use of these derivatives is noteworthy as they effectively inhibit fibrosis by suppressing epithelial-mesenchymal transition (EMT). This advancement could lead to new therapeutic options for patients suffering from fibrosis-related conditions.
Career Highlights
Kook Hwan Oh is associated with Immunomet Therapeutics Inc., where he continues to push the boundaries of pharmaceutical research. His work is characterized by a commitment to innovation and a focus on developing effective treatments for complex medical issues.
Collaborations
He collaborates with esteemed colleagues such as Sung Wuk Kim and Soon Im Lee, contributing to a dynamic research environment that fosters creativity and scientific advancement.
Conclusion
Kook Hwan Oh's contributions to the field of pharmaceuticals, particularly through his patent on N1-cyclic amine-N5-substituted biguanide derivatives, highlight his role as an influential inventor. His work not only advances medical science but also offers hope for effective treatments for fibrosis.